Stockreport

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Microbot Medical Inc.  (MBOT) 
Last microbot medical inc. earnings: 11/14 03:34 pm Check Earnings Report
US:NASDAQ Investor Relations: microbotmedical.com/investors
PDF U.S. Food and Drug Administration (FDA) Submission Expected by end of 2024 Clinical Data to be Presented at Medical Conference in Early 2025 BRAINTREE, Mass., Oct. [Read more]